Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance.
Desai
S D
SD
Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854, USA.
Mao
Y
Y
Sun
M
M
Li
T K
TK
Wu
J
J
Liu
L F
LF
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D002166:Camptothecin / Q000494:pharmacology*; D002352:Carrier Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D016207:Cytokines; D004264:DNA Topoisomerases, Type I / Q000096:biosynthesis / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D025842:SUMO-1 Protein; D059004:Topoisomerase I Inhibitors; D014452:Ubiquitins / Q000031:analogs & derivatives / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation
D000972:Antineoplastic Agents, Phytogenic; D002352:Carrier Proteins; D016207:Cytokines; D004791:Enzyme Inhibitors; D025842:SUMO-1 Protein; D059004:Topoisomerase I Inhibitors; D014452:Ubiquitins; C074034:ISG15 protein, human; D004264:DNA Topoisomerases, Type I; D002166:Camptothecin